Implantable glucose monitor developer Senseonics raised $10 million in a new round of equity financing, according to an SEC filing.
Senseonics is developing micro-sized sensors and connected smartphone apps for glucose monitoring. The device is inserted into a patients upper arm, just below the skin, and can connect wirelessly to a smartphone application.
The device is designed to last at least 90 days, display trends, history and issues allerts for impending hypo or hyperglycemic events, the company said.
Help employers find you! Check out all the jobs and post your resume
